1. Home
  2. NBTX vs FSP Comparison

NBTX vs FSP Comparison

Compare NBTX & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • FSP
  • Stock Information
  • Founded
  • NBTX 2003
  • FSP 1981
  • Country
  • NBTX France
  • FSP United States
  • Employees
  • NBTX N/A
  • FSP N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • FSP Real Estate Investment Trusts
  • Sector
  • NBTX Health Care
  • FSP Real Estate
  • Exchange
  • NBTX Nasdaq
  • FSP Nasdaq
  • Market Cap
  • NBTX 178.7M
  • FSP 159.5M
  • IPO Year
  • NBTX 2020
  • FSP N/A
  • Fundamental
  • Price
  • NBTX $3.41
  • FSP $1.53
  • Analyst Decision
  • NBTX Strong Buy
  • FSP
  • Analyst Count
  • NBTX 1
  • FSP 0
  • Target Price
  • NBTX $8.00
  • FSP N/A
  • AVG Volume (30 Days)
  • NBTX 7.6K
  • FSP 285.2K
  • Earning Date
  • NBTX 04-02-2025
  • FSP 04-29-2025
  • Dividend Yield
  • NBTX N/A
  • FSP 2.65%
  • EPS Growth
  • NBTX N/A
  • FSP N/A
  • EPS
  • NBTX N/A
  • FSP N/A
  • Revenue
  • NBTX N/A
  • FSP $115,994,000.00
  • Revenue This Year
  • NBTX N/A
  • FSP $4.36
  • Revenue Next Year
  • NBTX $221.06
  • FSP $0.81
  • P/E Ratio
  • NBTX N/A
  • FSP N/A
  • Revenue Growth
  • NBTX N/A
  • FSP N/A
  • 52 Week Low
  • NBTX $2.76
  • FSP $1.36
  • 52 Week High
  • NBTX $7.51
  • FSP $2.21
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 52.75
  • FSP 43.75
  • Support Level
  • NBTX $3.26
  • FSP $1.49
  • Resistance Level
  • NBTX $3.65
  • FSP $1.60
  • Average True Range (ATR)
  • NBTX 0.19
  • FSP 0.07
  • MACD
  • NBTX 0.02
  • FSP 0.01
  • Stochastic Oscillator
  • NBTX 35.00
  • FSP 28.12

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

Share on Social Networks: